Astonea Labs Posts Strong FY25 Financial Results Following Clarification Submission to BSE
Astonea Labs Ltd · Financial Result · 22 Sept 2026, 7:36 pm
Astonea Labs Posts Strong FY25 Financial Results Following Clarification Submission to BSE Astonea Labs clarified and submitted its standalone financial results for the half-year and full-year ended 31st Mar'25. For FY25, revenue from operations rose 21.6% YoY to ₹9,751.83 lakh versus ₹8,019.09 lakh in FY24. Profit after tax increased 31.4% YoY to ₹535.05 lakh from ₹407.01 lakh, while annual EPS improved to ₹6.94 from ₹5.36. For H2 FY25, revenue reached ₹5,024.80 lakh and net profit stood at ₹321.63 lakh. Net cash flows from operating activities strengthened to ₹924.95 lakh for FY25.
Original exchange filing (PDF)
More announcements from Astonea Labs Ltd
- Non-Applicability of Statement of Deviation & Variation for the half year ended 30th September, 2026 · 15 Nov 2026
- Revised Outcome of Board Meeting held on 14th November, 2026 · 15 Nov 2026
- Unaudited Financial Results (Standalone & Consolidated) for the half year ended 30th September, 2026 · 14 Nov 2026
- Outcome of Board Meeting held on 14th November, 2026 · 14 Nov 2026
- Astonea Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve unaudited Standalone and Consolidated .... · 14 Nov 2026
- Please find enclosed herewith an Intimation regarding change in the Corporate Identification Number (CIN) of the Company consequent upon alteration of the Object Clause of the Memorandum .... · 09 Oct 2026
- Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015 - Incorporation of Proposed Subsidiary- Longevity Science Private Limited · 08 Oct 2026
- Please find enclosed herewith resubmission of financial results for the financial year ended 31.03.2025, as the same was submitted in XBRL Version and as a part of outcome of the Board .... · 19 Sept 2026
